Civic Intelligence

Center for Genomic Interpretation

EIN 82-0918164 • 501(c)3 • Sandy, UT

Sandy, UT
Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

100th percentile

223.74x

Higher debt load relative to assets than 100% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2025

Liabilities / Revenue

99th percentile

29.98x

Higher debt load relative to revenue than 99% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2025

Net Margin

6th percentile

-267%

Higher net margin than 6% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2025

Top Officer Pay

90th percentile

$30,000

Higher top officer pay than 90% of similar nonprofits.

Top officer pay equals 179.9% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2025

Asset Growth

11th percentile

-95%

Faster asset growth than 11% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2024 to 2025

Revenue Growth

99th percentile

3674%

Faster revenue growth than 99% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2024 to 2025

Assets

Down

$121,566

Down $246,335 (-67%) from 2022

Liabilities

Up

$500,231

Up $1,853 (+0.4%) from 2022

Net Assets

-

No earlier filing loaded for comparison.

Revenue

Down

$32,152

Down $234,769 (-88%) from 2022

Expenses

Down

$280,340

Down $57,347 (-17%) from 2022

Net Income

Down

-$248,188

Down $177,422 (-251%) from 2022

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$600K$400K$200K$0-$200KAssets 2017: $8,478Liabilities 2017: $178Net Assets 2017: $8,3002017Assets 2018: $69,413Liabilities 2018: $68Net Assets 2018: $69,3452018Assets 2019: $82,211Liabilities 2019: $0Net Assets 2019: $82,2112019Assets 2020: $124,912Liabilities 2020: $144,800Net Assets 2020: -$19,8882020Assets 2021: $441,519Liabilities 2021: $501,230Net Assets 2021: -$59,7112021Assets 2022: $367,901Liabilities 2022: $498,378Net Assets 2022: -$130,4772022Assets 2023: $121,566Liabilities 2023: $500,2312023

Highlighted filing

2023

Assets$121,566
Liabilities$500,231
Net Assets-

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$400K$200K$0-$200K-$400KRevenue 2017: $20,533Expenses 2017: $12,233Net Income 2017: $8,3002017Revenue 2018: $205,337Expenses 2018: $144,293Net Income 2018: $61,0442018Revenue 2019: $273,713Expenses 2019: $260,847Net Income 2019: $12,8662019Revenue 2020: $123,769Expenses 2020: $225,868Net Income 2020: -$102,0992020Revenue 2021: $284,425Expenses 2021: $324,248Net Income 2021: -$39,8232021Revenue 2022: $266,921Expenses 2022: $337,687Net Income 2022: -$70,7662022Revenue 2023: $32,152Expenses 2023: $280,340Net Income 2023: -$248,1882023

Highlighted filing

2023

Revenue$32,152
Expenses$280,340
Net Income-$248,188

Filings

Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2023 to Dec 31, 2023
Mission and Program Overview

Mission

The mission of the Organization is to build an expertly curated, comprehensive human genetic variant database that, once established, will significantly contribute to the scientific research findings that will be published and made available to the public. Through our work we will identify genetic markers of disease, which is the first step to identifying cures for both hereditary and somatic diseases.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.